Concepedia
Statistics
Publications
8
Citations
222
H-Index
Active since
1997
Affiliations
Lund University(Current)
AstraZeneca (United Kingdom)
AstraZeneca (Sweden)
Charles River Laboratories (United Kingdom)
Cecilia Wikell is an author at Lund University specializing in pharmacology, medicine, and neuropharmacology.
Publications per year
1997–2016
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
Kevin Doyle, Hans Lönn, Helena Käck et al. · Journal of Medicinal Chemistry · 2016 · 87 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.
Cecilia Wikell, Peter B. F. Bergqvist, Stephan Hjorth et al. · PubMed · 1998 · 29 citations
Medicine, Pharmacokinetics, Pharmacology +14
Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
Cecilia Wikell, Gustav Apelqvist, Björn Carlsson et al. · PubMed · 2000 · 22 citations
Medicine, Pharmacokinetics, Pharmacology +16
Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges
Gustav Apelqvist, Cecilia Wikell, Bengt Hindfelt et al. · Psychopharmacology · 1999 · 21 citations
Medicine, Neuroscience, Pharmacology +10
Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity
Philip Gardiner, Cecilia Wikell, Steve Clifton et al. · British Journal of Pharmacology · 2016 · 20 citations · Full text
Life Sciences, Immunology, Pharmacology +12
1–5 of 8